Next Article in Journal
TET2 Promoter DNA Methylation and Expression Analysis in Pediatric B-Cell Acute Lymphoblastic Leukemia
Previous Article in Journal
Serum Thrombopoietin and cMpl Expression in Thrombocytopenia of Different Etiologies
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Hematology Reports
Volume 6
Issue 1
10.4081/hr.2014.5283
hematolrep-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
Hematology Reports is published by MDPI from Volume 14 Issue 1 (2022). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with PAGEPress.
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Case Report

Intracranial Hemorrhage in Patient Treated with Rivaroxaban

by
Michelle Molina
,
Virany H. Hillard
and
Robert Fekete
*
Department of Neurology, New York Medical College, Munger Pavilion, 4th Floor, 40 Sunshine Cottage Road, Valhalla, NY 10595, USA
*
Author to whom correspondence should be addressed.
Hematol. Rep. 2014, 6(1), 5283; https://doi.org/10.4081/hr.2014.5283
Submission received: 2 January 2014 / Revised: 12 February 2014 / Accepted: 24 March 2014 / Published: 28 March 2014

Abstract

Rivaroxaban is an oral factor Xa inhibitor used for stroke prevention in atrial fibrillation. There are currently no evidence-based guidelines for the treatment of hemorrhagic side effects of factor Xa inhibitors. We report a case of a thalamic hemorrhage in an 84 year-old right-handed female on rivaroxaban for treatment of atrial fibrillation. The patient had fallen down steps and became unresponsive. She was found to have diffuse scattered acute subarachnoid hemorrhage as well as intraventricular hemorrhage. Neurosurgical intervention was not required in this case, but controversy over decision making to pursue pro-coagulant therapy in the setting of worsening hemorrhage requiring emergent surgery is discussed.
Keywords: rivaroxaban; factor Xa inhibitor rivaroxaban; factor Xa inhibitor

Share and Cite

MDPI and ACS Style

Molina, M.; Hillard, V.H.; Fekete, R. Intracranial Hemorrhage in Patient Treated with Rivaroxaban. Hematol. Rep. 2014, 6, 5283. https://doi.org/10.4081/hr.2014.5283

AMA Style

Molina M, Hillard VH, Fekete R. Intracranial Hemorrhage in Patient Treated with Rivaroxaban. Hematology Reports. 2014; 6(1):5283. https://doi.org/10.4081/hr.2014.5283

Chicago/Turabian Style

Molina, Michelle, Virany H. Hillard, and Robert Fekete. 2014. "Intracranial Hemorrhage in Patient Treated with Rivaroxaban" Hematology Reports 6, no. 1: 5283. https://doi.org/10.4081/hr.2014.5283

APA Style

Molina, M., Hillard, V. H., & Fekete, R. (2014). Intracranial Hemorrhage in Patient Treated with Rivaroxaban. Hematology Reports, 6(1), 5283. https://doi.org/10.4081/hr.2014.5283

Article Metrics

Back to TopTop